Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders.Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamine transporter 2 inhibitor for the treatment of adults with tardive dyskinesia (TD).
Its other major pipeline products include elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of endometriosis and uterine fibroids and opicapone, a catechol-O-methyltransferase inhibitor (COMT inhibitor) intended for adult patients with Parkinson’s disease.It also develops drug candidates for the treatment of essential tremor and classic congenital adrenal hyperplasia.
The company has development and licencing partnerships with AbbVie Inc, BIAL–Portela & CA, S.A. and Mitsubishi Tanabe Pharma. Neurocrine is headquartered in San Diego, California, the US.
Neurocrine Biosciences Inc (NBIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
240 pages •
By Global Industry Analysts
• Apr 2021
- Global Human Reproductive Technologies Market to Reach $28.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Human Reproductive Technologies estimated at US$26.1 Billion in the year 2020, is projected to reach a revised size of US$28.2 Billion by 2027, growing at aCAGR of 1.1% over the...
Pectin is a carbohydrate found in all fruits and vegetables and is important for plant growth. Industrially, it is extracted from citrus peels or apple pomace, and is used as a gelling agent, thickener, water binder and stabilizer in foods, medicines, etc. This latest report “Pectin Market: Global Industry Trends, Share,...
As the global chemicals industry is at the onset of the recovery phase, companies are focusing on identifying and monetizing new opportunities in the industry. The majority of the chemical industries are likely to record volume growth of 4% to 8% in the short term, depending on the chemical sub-segment and product portfolio. A large volume...
The Global Industrial Ethernet Market size is expected to reach $15.3 billion by 2027, rising at a market growth of 7.2% CAGR during the forecast period. The adoption of industrial IoT is high due to the requirement for gathering data from several sources sensors integrated into machines) in a factory for real-time control, automation, motion,...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The cold chain packaging market was valued at USD 132.6 billion in 2020 and is expected to reach USD 346.3 billion by 2026, at a CAGR of 18.3% over the forecast period 2021 - 2026. - Cold chain packaging solutions are essential to the growth of the global trade in perishable products and the worldwide availability of food and health...
120 pages •
By Infiniti Research Limited
• Apr 2021
Global Ammonium Carbonate Market 2021-2025 The analyst has been monitoring the ammonium carbonate market and it is poised to grow by 391.38 thousand tons during 2021-2025, progressing at a CAGR of over 5% during the forecast period. Our report on ammonium carbonate market provides a holistic analysis, market size and forecast,...
The North America hydrolyzed collagen market is expected to grow from US$ 211.94 millionin 2019 to US$ 323.61 million by 2027; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027. Hydrolyzed collagen, also known as collagen hydrolysate, are collagen derivatives comprising short chains of amino acids. Shorter amino acid chains make...
Anesthesia is one of the most essential components for any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with...
Surgical Procedures Performed
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.